AR-15512 ophthalmic solution

AR-15512 · Aerie Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AR-15512 ophthalmic solution, covering 2024-08-06 to 2024-08-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease [Phase 2]

See pricing